FDA Approves Leqembi for At-Home Maintenance Treatment of Alzheimer Disease
The US Food and Drug Administration (FDA) has approved Leqembi IQLIK (lecanemab), for self-administered injection for maintenance treatment of Alzheimer...
FDA
Eisai scores FDA nod for subcutaneous Leqembi maintenance dose
Aiming to deliver blockbuster sales of its Alzheimer’s-disease-fighting antibody Leqembi in its 2027 fiscal year, Eisai has cleared a key...
